Embecta Corp (EMBC) - Total Liabilities
Based on the latest financial reports, Embecta Corp (EMBC) has total liabilities worth $1.88 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Embecta Corp current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Embecta Corp - Total Liabilities Trend (2019–2025)
This chart illustrates how Embecta Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Embecta Corp assets under control.
Embecta Corp Competitors by Total Liabilities
The table below lists competitors of Embecta Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Onity Group Inc.
NYSE:ONIT
|
USA | $11.69 Billion |
|
XAI Octagon Floating Rate & Alternative Income Term Trust
NYSE:XFLT
|
USA | $260.14 Million |
|
Bpost NV
BR:BPOST
|
Belgium | €4.74 Billion |
|
NICE Holdings Co. Ltd
KO:034310
|
Korea | ₩2.35 Trillion |
|
Orbit Technologies Ltd
TA:ORBI
|
Israel | ILA45.96 Million |
|
BMTC Group Inc
TO:GBT
|
Canada | CA$169.25 Million |
|
INTERGRATED DIA.H DL 025
F:8I8
|
Germany | €3.22 Billion |
|
Taeyoung Engineering & Construction Co.,Ltd.
KO:009415
|
Korea | ₩3.15 Trillion |
Liability Composition Analysis (2019–2025)
This chart breaks down Embecta Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See EMBC net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Embecta Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Embecta Corp (2019–2025)
The table below shows the annual total liabilities of Embecta Corp from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $1.74 Billion | -13.91% |
| 2024-09-30 | $2.02 Billion | -0.61% |
| 2023-09-30 | $2.04 Billion | +2.95% |
| 2022-09-30 | $1.98 Billion | +919.48% |
| 2021-09-30 | $194.00 Million | +16.87% |
| 2020-09-30 | $166.00 Million | +31.75% |
| 2019-09-30 | $126.00 Million | -- |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more